Lysosome-targeting chimaeras for degradation of extracellular proteins | Nature
Lysosome-targeting chimaeras—in which a small molecule or antibody is connected to a glycopeptide ligand to form a conjugate that can bind a cell-surface lysosome-shuttling receptor and a protein target—are used to achieve the targeted degradation of extracellular and membrane proteins.
Subjects Carbohydrate chemistry Chemical tools Lysosomes Transporters Abstract The majority of therapies that target individual proteins rely on specific activity-modulating interactions with the target protein—for example, enzyme inhibition or ligand blocking. However, several major classes of therapeutically relevant proteins have unknown or inaccessible activity profiles and so cannot be targeted by such strategies. Protein-degradation platforms such as proteolysis-targeting chimaeras (PROTACs) 1 , 2 and others (for example, dTAGs 3 , Trim-Away 4 , chaperone-mediated autophagy targeting 5 a
Explore this link on the map →saved by
related reading
- Protein degradation reaches further outnature.com
- Lysosome-targeting chimeras evolve | Nature Chemical Biologynature.com
- Gap Mapgap-map.org
- Cycling of the integral membrane glycoprotein, LEP100, between plasma membrane and lysosomes: kinetic and morphological analysis - PubMedpubmed.ncbi.nlm.nih.gov
- Engineering Plastic-Degrading Enzymes and PCSK9 Binders with Protein AI Toolsblog.latch.bio
- Reversal of protein chemical aging by enzymatic deglycation | Nature Communicationsnature.com
- Checking your browser - reCAPTCHApmc.ncbi.nlm.nih.gov
- Has pancreatic cancer met its match?worksinprogress.co
- The ins and outs of phospholipid asymmetry in the plasma membrane: roles in health and disease - PMCncbi.nlm.nih.gov
- Manifold Bio | Tissue-targeted medicines, designed in vivomanifold.bio
- UGCG and the glycosphingolipid rheostat: a metabolic checkpoint governing immune activation and tumor immune evasion | Signal Transduction and Targeted Therapynature.com
- Frontiers | Therapeutic Antibodies against Intracellular Tumor Antigensfrontiersin.org